Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 31 studies | 34% ± 17% | |
fibroblast | 30 studies | 29% ± 11% | |
pericyte | 23 studies | 29% ± 9% | |
endothelial cell | 20 studies | 28% ± 11% | |
ciliated cell | 19 studies | 41% ± 12% | |
astrocyte | 17 studies | 35% ± 16% | |
oligodendrocyte | 16 studies | 34% ± 14% | |
oligodendrocyte precursor cell | 16 studies | 39% ± 17% | |
basal cell | 14 studies | 26% ± 8% | |
myofibroblast cell | 12 studies | 34% ± 13% | |
GABAergic neuron | 11 studies | 50% ± 21% | |
glutamatergic neuron | 11 studies | 43% ± 24% | |
epithelial cell | 9 studies | 31% ± 20% | |
connective tissue cell | 8 studies | 31% ± 15% | |
neuron | 8 studies | 46% ± 19% | |
abnormal cell | 7 studies | 31% ± 10% | |
interneuron | 7 studies | 53% ± 19% | |
club cell | 6 studies | 27% ± 10% | |
retinal cone cell | 6 studies | 41% ± 24% | |
endothelial cell of vascular tree | 6 studies | 24% ± 10% | |
adipocyte | 5 studies | 29% ± 16% | |
cardiac muscle cell | 5 studies | 39% ± 7% | |
respiratory goblet cell | 5 studies | 29% ± 13% | |
type II pneumocyte | 5 studies | 20% ± 2% | |
retinal ganglion cell | 4 studies | 38% ± 9% | |
capillary endothelial cell | 4 studies | 23% ± 5% | |
Mueller cell | 4 studies | 22% ± 8% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 26% ± 9% | |
muscle cell | 4 studies | 42% ± 14% | |
neural crest cell | 3 studies | 25% ± 2% | |
GABAergic interneuron | 3 studies | 45% ± 6% | |
granule cell | 3 studies | 30% ± 5% | |
progenitor cell | 3 studies | 34% ± 10% | |
brush cell | 3 studies | 31% ± 14% | |
retina horizontal cell | 3 studies | 29% ± 19% | |
endothelial cell of artery | 3 studies | 20% ± 4% | |
vein endothelial cell | 3 studies | 26% ± 14% | |
pancreatic ductal cell | 3 studies | 44% ± 21% | |
neural progenitor cell | 3 studies | 49% ± 9% | |
ependymal cell | 3 studies | 51% ± 13% | |
enteroendocrine cell | 3 studies | 22% ± 5% | |
adventitial cell | 3 studies | 25% ± 6% | |
chondrocyte | 3 studies | 25% ± 7% | |
transit amplifying cell | 3 studies | 25% ± 8% | |
luminal cell of prostate epithelium | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6560.53 | 458 / 459 | 100% | 72.65 | 1113 / 1118 |
prostate | 100% | 9053.47 | 245 / 245 | 98% | 30.31 | 493 / 502 |
brain | 99% | 4416.26 | 2605 / 2642 | 100% | 56.18 | 702 / 705 |
lung | 100% | 7685.49 | 576 / 578 | 98% | 39.56 | 1135 / 1155 |
ovary | 100% | 8006.03 | 180 / 180 | 97% | 28.83 | 419 / 430 |
uterus | 100% | 8205.90 | 170 / 170 | 95% | 35.56 | 438 / 459 |
esophagus | 98% | 7891.20 | 1411 / 1445 | 97% | 49.29 | 178 / 183 |
bladder | 100% | 14647.48 | 21 / 21 | 92% | 26.58 | 463 / 504 |
stomach | 100% | 8792.36 | 359 / 359 | 91% | 23.94 | 259 / 286 |
pancreas | 95% | 2925.00 | 310 / 328 | 92% | 19.96 | 164 / 178 |
skin | 100% | 6830.06 | 1801 / 1809 | 85% | 30.21 | 400 / 472 |
intestine | 95% | 9540.02 | 918 / 966 | 87% | 18.68 | 461 / 527 |
thymus | 98% | 3600.81 | 640 / 653 | 81% | 14.68 | 489 / 605 |
adrenal gland | 100% | 6781.41 | 258 / 258 | 50% | 7.74 | 115 / 230 |
kidney | 62% | 1614.45 | 55 / 89 | 70% | 11.52 | 629 / 901 |
adipose | 100% | 6291.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 18093.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.91 | 1 / 1 |
spleen | 99% | 4602.50 | 239 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 5446.97 | 796 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 5440.18 | 805 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 24.72 | 41 / 45 |
liver | 23% | 443.89 | 53 / 226 | 66% | 16.94 | 267 / 406 |
eye | 0% | 0 | 0 / 0 | 23% | 2.63 | 18 / 80 |
peripheral blood | 0% | 1.51 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008154 | Biological process | actin polymerization or depolymerization |
GO_0070358 | Biological process | actin polymerization-dependent cell motility |
GO_0007411 | Biological process | axon guidance |
GO_0030054 | Cellular component | cell junction |
GO_0030175 | Cellular component | filopodium |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0030027 | Cellular component | lamellipodium |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0017124 | Molecular function | SH3 domain binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
GO_0050699 | Molecular function | WW domain binding |
GO_0005522 | Molecular function | profilin binding |
Gene name | ENAH |
Protein name | Protein enabled homolog ENAH actin regulator Mammalian enabled variant 11a Mammalian enabled variant pan |
Synonyms | MENA |
Description | FUNCTION: Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. ENAH induces the formation of F-actin rich outgrowths in fibroblasts. Acts synergistically with BAIAP2-alpha and downstream of NTN1 to promote filipodia formation (By similarity). . |
Accessions | A0A075B6E5 ENST00000366844.7 [Q8N8S7-1] A0A0U1RQP7 ENST00000497899.6 Q8N8S7 ENST00000284563.7 ENST00000366843.7 [Q8N8S7-2] A0A097PIC4 A0A0U1RRM6 ENST00000696609.1 ENST00000635051.1 A0A8Q3WLE0 A0A097PID1 |